moxalactam has been researched along with salvianolic acid a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gao, Z; Jing, S; Luan, Y; Mu, D; Wang, D; Wang, L; Wang, T; Wang, Y; Xiang, H; Yang, P | 1 |
1 other study(ies) available for moxalactam and salvianolic acid a
Article | Year |
---|---|
The combination of salvianolic acid A with latamoxef completely protects mice against lethal pneumonia caused by methicillin-resistant
Topics: Aminoacyltransferases; Animals; Bacterial Proteins; Biofilms; Caffeic Acids; Cysteine Endopeptidases; Drug Synergism; Female; Humans; Lactates; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Moxalactam; Pneumonia; Staphylococcal Infections | 2020 |